Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | KIR2DS2///KIR2DS4///KIR2DS1 |
| Upstream (Parents) |
|---|
| (<<) NRIP1 → KIR2DS2///KIR2DS4///KIR2DS1 |
| (<<) SOCS6 → KIR2DS2///KIR2DS4///KIR2DS1 |
| (<<) TTC23 → KIR2DS2///KIR2DS4///KIR2DS1 |
| Downstream (Children) |
|---|
| KIR2DS2///KIR2DS4///KIR2DS1 → CRISP1 (>>) |
| KIR2DS2///KIR2DS4///KIR2DS1 → RRP7B///POLDIP3///RRP7A (>>) |
| KIR2DS2///KIR2DS4///KIR2DS1 → PYY (>>) |
| KIR2DS2///KIR2DS4///KIR2DS1 → KDM5B (>>) |
| KIR2DS2///KIR2DS4///KIR2DS1 → GPR50 (>>) |
| KIR2DS2///KIR2DS4///KIR2DS1 → RPL35A (>>) |
| KIR2DS2///KIR2DS4///KIR2DS1 → SPG20 (>>) |
| KIR2DS2///KIR2DS4///KIR2DS1 → CPEB1 (>>) |
| KIR2DS2///KIR2DS4///KIR2DS1 → TULP1 (>>) |
| KIR2DS2///KIR2DS4///KIR2DS1 → PMS2L3 (>>) |
| KIR2DS2///KIR2DS4///KIR2DS1 → PRKACA (>>) |
| KIR2DS2///KIR2DS4///KIR2DS1 → FLJ11710 (>>) |
| KIR2DS2///KIR2DS4///KIR2DS1 → SDK2 (>>) |
| KIR2DS2///KIR2DS4///KIR2DS1 → LOC100130354 (>>) |
